LYRM2 and hepatocellular carcinoma: Functionally, the transfection of HIF‐1α shRNA effectively abolished HIF‐1α expression in HCC cells, and subsequently inhibiting the glucose metabolism reprogramming induced by LYRM2 overexpression (Figure 8A–E).